Decoy Therapeutics issues warrants for 2,368,868 shares at USD 3.25 each
Bitget2026/09/22 16:51- Decoy Therapeutics entered a warrant inducement deal for immediate exercise of 1,184,434 Series B Milestone Warrants at $3.25.
- Expected gross proceeds of about $3.85 million; closing targeted for Sept. 23, 2026.
- Series A Milestone Warrants and Series C Milestone Warrants exercise prices cut to $3.25 from $5.91.
- Investor to receive new unregistered warrants for 2,368,868 shares at $3.25, exercisable after stockholder approval; five-year term.
- Company plans to file an SEC registration statement covering resale of shares issuable upon exercise of the New Warrants.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Treasury Buys $6 Billion of Bonds as Bitcoin Battles 24-Year-High Yields
Google (GOOGL.US) ad tech monopoly compensation case approved to proceed: publishers can claim over $3.2 billion in total damages
Google faces a $3.2 billion compensation lawsuit for monopolizing advertising technology.
Canadian Dollar falls as oil prices dip, US Dollar gains strength
Anthropic reportedly scheduled pre-IPO Investor Day for October 14, targeting listing in November
Reportedly, as the listing date approaches, Anthropic plans to hold a pre-IPO investor day event.